ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Recommendation By Patients; report Of Protocol Committee

August 9, 1996

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

November 19, 1993

Interview: A Conversation with Robert Carlson

October 5, 2012

NCI’s Douglas Lowy and John Schiller Honored with National Medal

December 12, 2014

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003